Non-surgical procedures driving the downturn in cosmetic operations
Nearly 90% of practitioners who took part in a study believe the 40% drop in cosmetic operations is due to people opting for non-surgical procedures.
The research by CCR Expo showed that Botox, dermal fillers, chemical peels, medical needling and teeth whitening make up the bulk of practitioner business.
Alison Willis, division director of CCR Expo, explained: ‘Our show uniquely focuses on both the surgical and non-surgical aspects of the aesthetics medicine market.
‘So, when the fall in cosmetic operations was reported we decided to explore if this had been influenced by an increase in non-surgical activity.
‘Most experts we questioned felt it had, and went on to give us considerable insights into the treatments people are having and why.’
The most common non-surgical treatments
When asked which non-surgical treatments women are most commonly having, the practitioners studied mentioned 22 treatments but two dominated; Botox, cited by 90% of practitioners and dermal fillers nominated by 86%.
Two fifths (42%) said chemical peels are a top treatment among female patients, laser hair removal was suggested by 36%, teeth whitening by a third (33%) and non-surgical facelifts by 31%.
Interestingly, 6% said that vaginal rejuvenation is the treatment they are commonly being asked for, and this group said the procedure makes-up the bulk of their business.
In terms of male clients, the respondents identified 20 treatments which are most popular and Botox again topped the list, nominated by 83%.
However, in contrast to women, the second most popular choice was teeth whitening, with 44% of practitioners saying this is the treatment men are opting for.
Dermal fillers came third, mentioned by 36%.
According to one in five, laser hair removal is also a common request among male patients, with chemical peels the fifth most popular treatment choice, nominated by 17%.
Over 100 leading surgeons, doctors, nurses, dermatologists, dentists and practice managers working within the UK aesthetic medicine market took part in the study.